A newly spotlighted clinical study aims to deepen our understanding of how major traumatic events are transmitted across generations and affect resilience in children. The trial, sponsored by the Institut National de la Santé Et de la Recherche Médicale in France, is currently recruiting participants. It leverages cutting-edge techniques like MRI, cognitive and psychological assessments, and cortisol sampling to explore intergenerational trauma.
In This Article
- What does this study address?
- What methodologies and interventions are employed?
- Potential impacts of the study
- FAQs
- Key Takeaways
- Disclaimer
- Related link
What does this study address?
The trial, officially titled “Child Cognitive-Affective Resilience Following 13-11 Event: A Pluridisciplinary Study of Intergenerational Transmission of a Traumatic Event,” investigates how exposure to trauma shapes resilience capabilities in future generations. It focuses on factors such as cognition, psychological profiles, and biological markers to better understand these complex mechanisms.
What methodologies and interventions are employed?
Participants will undergo a multidisciplinary assessment combining psychological tests, cognitive performance evaluations, magnetic resonance imaging (MRI), and biological sampling to measure cortisol levels. Cortisol, a stress hormone, is often analyzed as a biomarker for trauma-related physiological changes.
Each intervention is conducted under stringent safety and ethical guidelines. MRI scans generate high-resolution brain images, shedding light on structural and functional adaptations potentially related to trauma. Behavioral and psychological evaluations provide complementary insights into emotional and cognitive responses, while cortisol samples link physiological indicators to psychological findings.
Potential impacts of the study
The findings could inform clinical protocols for managing intergenerational trauma and fostering resilience in affected populations. The scientific data gathered may shape policy decisions or lead to innovation in targeted therapy programs aimed at families impacted by large-scale traumatic events.
Healthcare professionals, neuroscientists, and those involved in trauma care may benefit from integrating these insights into their practices, potentially supporting better child developmental outcomes in post-trauma settings.
FAQs
- 1. Who sponsors this trial?
- The study is sponsored by the Institut National de la Santé Et de la Recherche Médicale in France.
- 2. What is the main focus of the study?
- It investigates intergenerational trauma, resilience development, and the physiological and psychological impacts of exposure to traumatic events.
- 3. Are recruitment efforts ongoing?
- Yes, recruitment for participants is currently active.
Key Takeaways
This unique multidisciplinary study offers an opportunity to advance our understanding of how trauma impacts children and subsequent generations. Its results could lead to significant developments in therapeutic practices and public health policies addressing resilience and trauma.
Disclaimer
The information provided herein is intended for healthcare professionals and regulatory teams. It is not a substitute for legal or medical advice.
Related link
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07203443?term=medical+device